Market Value2,160,261,525
Total Holdings55
File Date2023-09-06
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
RETA / Reata Pharmaceuticals Inc - Class A
KDNY / Chinook Therapeutics Inc
NKTX / Nkarta, Inc.
TSVT / 2seventy bio, Inc.
SGEN / Seagen Inc Put
IMGN / ImmunoGen, Inc. Put
DCPH / Deciphera Pharmaceuticals, Inc.
BIIB / Biogen Inc.
QURE / uniQure N.V.
ACRS / Aclaris Therapeutics, Inc.
EXEL / Exelixis, Inc.
DICE / DICE Therapeutics Inc
JNCE / Jounce Therapeutics Inc
ZNTL / Zentalis Pharmaceuticals, Inc.
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
DYN / Dyne Therapeutics, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock) Put
SWTX / SpringWorks Therapeutics, Inc.
FDMT / 4D Molecular Therapeutics, Inc.
PLRX / Pliant Therapeutics, Inc.
PACB / Pacific Biosciences of California, Inc.
BEAM / Beam Therapeutics Inc.
ALKS / Alkermes plc
MLTX / MoonLake Immunotherapeutics
IPSC / Century Therapeutics, Inc.
ATXS / Astria Therapeutics, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
GHRS / GH Research PLC
GH / Guardant Health, Inc.
INSM / Insmed Incorporated
AXSM / Axsome Therapeutics, Inc.
NRIX / Nurix Therapeutics, Inc.
FGEN / FibroGen, Inc. Call
NTLA / Intellia Therapeutics, Inc.
INKT / MiNK Therapeutics, Inc.
TVTX / Travere Therapeutics, Inc.
RPTX / Repare Therapeutics Inc.
JAZZ / Jazz Pharmaceuticals plc
IMUX / Immunic, Inc.
PNT / POINT Biopharma Global Inc.
ANIP / ANI Pharmaceuticals, Inc.
ISEE / IVERIC bio Inc
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
ABOS / Acumen Pharmaceuticals, Inc.
EDIT / Editas Medicine, Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
VRDN / Viridian Therapeutics, Inc.
RLMD / Relmada Therapeutics, Inc.
ETNB / 89bio, Inc.
NKTR / Nektar Therapeutics
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
GERN / Geron Corporation
PRTA / Prothena Corporation plc Put
SLN / Silence Therapeutics plc - Depositary Receipt (Common Stock)
ITCI / Intra-Cellular Therapies, Inc.
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
MORF / Morphic Holding, Inc.
NUVB / Nuvation Bio Inc.
TERN / Terns Pharmaceuticals, Inc.
IMVT / Immunovant, Inc.
IONS / Ionis Pharmaceuticals, Inc.
DVAX / Dynavax Technologies Corporation
ZURA / Zura Bio Limited
EWTX / Edgewise Therapeutics, Inc.
ETNB / 89bio, Inc. Put
VIGL / Vigil Neuroscience, Inc.
AGEN / Agenus Inc.
ALLK / Allakos Inc.
HRTX / Heron Therapeutics, Inc.
INZY / Inozyme Pharma, Inc.
RAPT / RAPT Therapeutics, Inc.